查詢結果分析
相關文獻
- Clopidogrel-associated Severe Isolated Thrombocytopenia--A Case Report
- 牙齦異常出血與特發性血小板減少紫斑症--病例報告
- Immunological Studies of Children with Anaphylactoid Purpura
- Purpura Fulminans in Children: Report of Two Cases
- The Role of Heparin in Treatment of Purpura Fulminans: Experience in Four Cases
- Idiopathic Thrombocytopenic Purpura Preceding Malignant Lymphoma: Report of One Case
- Gastrointestinal Involvement as the Initial manifestation in Children with Henoch-Schonlein Purpura--Clinical Analysis of 27 Cases
- 兒童特發性紫斑症
- Chamaesyce maculata L., a New Addition to the Flora of Taiwan
- 以不尋常環形紫斑表現的白血球破碎性血管炎
頁籤選單縮合
題名 | Clopidogrel-associated Severe Isolated Thrombocytopenia--A Case Report=藥物(Clopidogrel)引起之嚴重性單獨血小板過低--病例報告 |
---|---|
作者 | 蘇峻弘; 蔡青峰; 翁國昌; 蕭培靜; 林正盛; 陳國勳; 林明正; 吳得進; 林中生; Su, Chen-hung; Tsai, Chin-feng; Ueng, Kwo-chang; Shiao, Pei-gin; Lin, Cheng-sheng; Chen, Kwo-shuen; Lin, Men-cheng; Wu, Der-jinn; Lin, Chung-sheng; |
期刊 | Acta Cardiologica Sinica |
出版日期 | 20040900 |
卷期 | 20:3 2004.09[民93.09] |
頁次 | 頁182-186 |
分類號 | 418.2321 |
語文 | eng |
關鍵詞 | 血小板減少症; 紫斑; Clopidogrel; Thrombocytopenia; Purpura; |
中文摘要 | Clopidogrel 是近三年來常使用的新上市抗血小板藥物,由於安全性已受到廣泛認同而被普遍使用且幾乎完全取代Ticlopidine,其腸胃道副作用亦明顯少於 Aspirin;雖然安全,但近年來仍不乏該藥物所造成的血液病變,例如TTP(thrombotic thrombocytopenic purpura)及HUS(hemolytic uremic syndrome),但目前僅有一病例報告造成嚴重性單獨血小板減少症。我們報告一位患者在服用Clopidogrel一個月後,出現嚴重性單獨血小板減少情形,期間並未使用其他可能導致血小板減少之藥物,亦無任何臨床證據顯示為TTP、HUS或DIC。除了入院當天輸血小板八個單位之外,我們並未給予病患其他相關的治療,血小板數目於停藥後100個小時內迅速而明顯的上昇,並回到正常範圍。 |
英文摘要 | Clopidogrel is a new oral antiplatelet agent with structure and mechanism of action similar to ticlopidine. It has replaced ticlopidine for many years due to significantly lower side effects and simpler dosing regimen. Cases of thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) associated with clopidogrel were reported in recent years, but only 1 case of isolated profound thrombocytopenia associated with clopidogrel was ever reported. We present our experience with a case of severe isolated thrombocytopenia without evidence of TTP and HUS after clopidogrel administration. No drug possibly associated with thrombocytopenia was prescribed concomitantly. Platedlet count recovered rapidly after discontinuation of clopidogrel and 8 units of platelet transfusion. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。